Diagnostic accuracy of early biomarkers for acute coronary syndrome (ACS) (2012)
posterposted on 2020-04-22, 11:40 authored by Christopher CarrollChristopher Carroll, Stephen GoodacreStephen Goodacre, John Stevens, Joanna LeavissJoanna Leaviss
Background: Current practice for suspected ACS involves troponin testing 10-12 hours after symptom onset to diagnose myocardial infarction (MI).
Aim: To estimate the diagnostic accuracy of early biomarkers
for MI to determine if an earlier, accurate decision was possible
Rationale: Early discharge of patients with no or low risk of ACS will result in cost savings and reduced healthcare and patient burden.
EthicsThere is no personal data or any that requires ethical approval
PolicyThe data complies with the institution and funders' policies on access and sharing
Sharing and access restrictionsThe data can be shared openly
- The file formats are open or commonly used
Methodology, headings and units
- Headings and units are explained in the files